Prevalence and Severity of Potential Drug–Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy

por Bachmann, Paula, Frahm, Niklas, Debus, Jane Louisa, Mashhadiakbar, Pegah, Langhorst, Silvan Elias, Streckenbach, Barbara, Baldt, Julia, Heidler, Felicita, Hecker, Michael, Zettl, Uwe Klaus
Publicado 2022

Associated factors of potential drug-drug interactions and drug–food interactions in patients with multiple sclerosis

por Debus, Jane Louisa, Bachmann, Paula, Frahm, Niklas, Mashhadiakbar, Pegah, Langhorst, Silvan Elias, Streckenbach, Barbara, Baldt, Julia, Heidler, Felicita, Hecker, Michael, Zettl, Uwe Klaus
Publicado 2022

Therapy of women with multiple sclerosis: an analysis of the use of drugs that may have adverse effects on the unborn child in the event of (unplanned) pregnancy

por Haker, Marie-Celine, Frahm, Niklas, Hecker, Michael, Langhorst, Silvan Elias, Mashhadiakbar, Pegah, Debus, Jane Louisa, Streckenbach, Barbara, Baldt, Julia, Heidler, Felicita, Zettl, Uwe Klaus
Publicado 2023

Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases

por Hecker, Michael, Frahm, Niklas, Bachmann, Paula, Debus, Jane Louisa, Haker, Marie-Celine, Mashhadiakbar, Pegah, Langhorst, Silvan Elias, Baldt, Julia, Streckenbach, Barbara, Heidler, Felicita, Zettl, Uwe Klaus
Publicado 2022